NCT05729932View on ClinicalTrials.gov

Cannabis and Opioid Use Disorder

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Opioid Use Disorder
Interventions
DRUG

Inhaled vaporized cannabis

Double-blind cannabis and placebo doses, administered through vaporizer

DRUG

Intransal opioid

Double-blind opioid and placebo doses, administered intranasal route

Trial Locations (1)

40508

RECRUITING

Center on Drug and Alcohol Research, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Kentucky

OTHER